Related Experiment Video
Updated: Apr 28, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
[How to safely and effectively administer aminoglycoside antibiotics]
Aminoglycoside antibiotics (AA) are crucial for treating Gram-negative infections but have narrow therapeutic windows and risks of ototoxicity and nephrotoxicity. Monitoring drug levels is essential for efficacy and safety.
Area of Science:
- Pharmacology
- Microbiology
- Toxicology
Background:
- Aminoglycoside antibiotics (AA) are vital for treating serious aerobic Gram-negative bacterial infections.
- They function by irreversibly binding to the 16S rRNA of the bacterial 30S ribosomal subunit, disrupting protein synthesis.
Discussion:
- The bactericidal effect of AA is linked to oxygen free radicals, serum drug concentration, and post-antibiotic effect.
- Achieving a C max./MIC ratio greater than 8-12 is associated with enhanced efficacy.
- Treatment requires careful monitoring of both peak (C max) and trough (C min) drug concentrations.
Key Insights:
- AA exhibit a narrow therapeutic window, necessitating vigilant therapeutic drug monitoring.
- Ototoxicity and nephrotoxicity are significant, often irreversible, side effects limiting AA use.
- Despite limitations, AA remain indispensable antibacterial agents in clinical practice.
Outlook:
- Further research into optimizing AA dosing strategies to maximize efficacy while minimizing toxicity is warranted.
- Development of novel aminoglycoside derivatives with improved safety profiles could expand their therapeutic applications.
- Understanding the precise mechanisms of AA-induced toxicity may lead to targeted interventions for prevention or mitigation.
Related Concept Videos
Dosage Regimen: Multiple Oral Dosage
Dosage Interval and Administration Route: Determination Methods
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Estimation of k and VD of Aminoglycosides
Inhibitors of Bacterial Protein Synthesis

